Geode Capital Management
TMDX icon

Geode Capital Management’s Transmedics TMDX Stock Holding History

Geode Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83.4M Buy
839,155
+22,681
+3% +$2.96M 0.01% 1205
2025
Q4 		$99.3M Buy
816,474
+2,903
+0.4% +$364K 0.01% 1082
2025
Q3 		$91.3M Buy
813,571
+8,921
+1% +$1.04M 0.01% 1129
2025
Q2 		$108M Buy
804,650
+11,241
+1% +$1.23M 0.01% 982
2025
Q1 		$53.4M Buy
793,409
+20,665
+3% +$1.42M ﹤0.01% 1342
2024
Q4 		$48.2M Buy
772,744
+8,954
+1% +$833K ﹤0.01% 1458
2024
Q3 		$120M Buy
763,790
+10,106
+1% +$1.56M 0.01% 869
2024
Q2 		$114M Buy
753,684
+30,246
+4% +$3.63M 0.01% 854
2024
Q1 		$53.5M Buy
723,438
+22,764
+3% +$1.88M ﹤0.01% 1308
2023
Q4 		$55.3M Buy
700,674
+34,751
+5% +$2.1M 0.01% 1281
2023
Q3 		$36.5M Buy
665,923
+23,272
+4% +$1.68M ﹤0.01% 1435
2023
Q2 		$54M Buy
642,651
+41,936
+7% +$3.21M 0.01% 1192
2023
Q1 		$45.5M Buy
600,715
+30,433
+5% +$2.1M 0.01% 1265
2022
Q4 		$35.2M Buy
570,282
+25,644
+5% +$1.36M ﹤0.01% 1388
2022
Q3 		$22.7M Buy
544,638
+63,265
+13% +$2.75M ﹤0.01% 1641
2022
Q2 		$15.1M Sell
481,373
-1,925
-0.4% -$51.3K ﹤0.01% 1965
2022
Q1 		$13M Buy
483,298
+27,858
+6% +$499K ﹤0.01% 2167
2021
Q4 		$8.73M Buy
455,440
+18,559
+4% +$465K ﹤0.01% 2550
2021
Q3 		$14.5M Buy
436,881
+15,142
+4% +$463K ﹤0.01% 2185
2021
Q2 		$14M Buy
421,739
+14,783
+4% +$410K ﹤0.01% 2222
2021
Q1 		$16.9M Buy
406,956
+40,907
+11% +$1.26M ﹤0.01% 1983
2020
Q4 		$7.28M Buy
366,049
+34,721
+10% +$514K ﹤0.01% 2379
2020
Q3 		$4.57M Buy
331,328
+143,530
+76% +$2.46M ﹤0.01% 2444
2020
Q2 		$3.37M Buy
187,798
+43,081
+30% +$674K ﹤0.01% 2543
2020
Q1 		$1.75M Buy
144,717
+21,486
+17% +$360K ﹤0.01% 2740
2019
Q4 		$2.34M Buy
123,231
+40,742
+49% +$748K ﹤0.01% 2923
2019
Q3 		$1.96M Buy
82,489
+3,863
+5% +$92.6K ﹤0.01% 2954
2019
Q2 		$2.28M Buy
+78,626
New +$2.15M ﹤0.01% 2867

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Geode Capital Management's TMDX Position: Q1 2026 in Review

Geode Capital Management increased its Transmedics (TMDX) stake by 2.8% in Q1 2026, buying an estimated $2.96M and bringing the position to 839,155 shares worth $83.4M. The position accounts for 0.01% of the portfolio, ranked #1205.

Geode Capital Management first reported a position in TMDX in Q2 2019 and has held it in 28 quarters since. The position peaked at $120M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Geode Capital Management held 839,155 shares of Transmedics worth $83.4M as of Q1 2026.
  • Geode Capital Management bought 22,681 Transmedics shares in Q1 2026, an estimated $2.96M.
  • Transmedics made up 0.01% of Geode Capital Management's portfolio in Q1 2026, its #1205 holding.
  • Geode Capital Management first reported a position in Transmedics in Q2 2019 and has held it in 28 quarters since.
  • Geode Capital Management's Transmedics position peaked at $120M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.